These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25595641)

  • 21. Effects of renal denervation on end organ damage in hypertensive patients.
    Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M; Leiner T
    Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
    J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
    Vink EE; Verloop WL; Siddiqi L; van Schelven LJ; Liam Oey P; Blankestijn PJ
    Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk.
    Zaldivia MT; Rivera J; Hering D; Marusic P; Sata Y; Lim B; Eikelis N; Lee R; Lambert GW; Esler MD; Htun NM; Duval J; Hammond L; Eisenhardt SU; Flierl U; Schlaich MP; Peter K
    Hypertension; 2017 Feb; 69(2):323-331. PubMed ID: 27956575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
    Lambert T; Blessberger H; Gammer V; Nahler A; Grund M; Kerschner K; Buchmayr G; Saleh K; Kammler J; Steinwender C
    Clin Cardiol; 2014 May; 37(5):307-11. PubMed ID: 24700288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A; Schmieder R; Lell M; Janka R; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP; Papademetriou V; Dimitriadis KS; Kasiakogias A; Tsiachris D; Worthley MI; Sinhal AR; Chew DP; Meredith IT; Malaiapan Y; Thomopoulos C; Kallikazaros I; Tousoulis D; Worthley SG
    Int J Cardiol; 2015 Dec; 201():345-50. PubMed ID: 26301677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension.
    Bergo KK; Larstorp AC; Hoffmann P; Hjørnholm U; Cataliotti A; Høieggen A; Rostrup M; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):31-40. PubMed ID: 32633141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
    Kądziela J; Prejbisz A; Kostka-Jeziorny K; Dudek D; Narkiewicz K; Sadowski J; Lekston A; Gziut A; Więcek A; Buszman P; Kleinrok A; Kochman J; Czarnecka D; Januszewicz A; Witkowski A
    Kardiol Pol; 2016; 74(9):961-8. PubMed ID: 27160171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH; Sayed MM; Reil JC; Lavall D; Ukena C; Linz D; Mahfoud F; Böhm M
    JACC Cardiovasc Interv; 2015 Jun; 8(7):972-80. PubMed ID: 26003031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal sympathetic denervation induces changes in heart rate variability and is associated with a lower sympathetic tone.
    Hoogerwaard AF; de Jong MR; Adiyaman A; Smit JJJ; Delnoy PPHM; Heeg JE; van Hasselt BAAM; Ramdat Misier AR; Rienstra M; van Gelder IC; Elvan A
    Clin Res Cardiol; 2019 Jan; 108(1):22-30. PubMed ID: 29943270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy.
    Tsioufis C; Papademetriou V; Dimitriadis K; Tsiachris D; Thomopoulos C; Kasiakogias A; Kordalis A; Kefala A; Koutra E; Lau EO; Grassi G; Stefanadis C
    J Hypertens; 2015 Feb; 33(2):346-53. PubMed ID: 25380167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.
    Mahfoud F; Townsend RR; Kandzari DE; Kario K; Schmieder RE; Tsioufis K; Pocock S; David S; Patel K; Rao A; Walton A; Bloom JE; Weber T; Suppan M; Lauder L; Cohen SA; McKenna P; Fahy M; Böhm M; Weber MA
    J Am Coll Cardiol; 2021 Jun; 77(23):2909-2919. PubMed ID: 33957242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal sympathetic denervation: early impact on ambulatory resistant hypertension.
    Schwerg M; Heupel C; Strajnic D; Baumann G; Laule M; Stangl V; Stangl K
    J Clin Hypertens (Greenwich); 2014 Jun; 16(6):406-11. PubMed ID: 24766570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.
    Feyz L; Theuns DA; Bhagwandien R; Strachinaru M; Kardys I; Van Mieghem NM; Daemen J
    Clin Res Cardiol; 2019 Jun; 108(6):634-642. PubMed ID: 30413869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
    de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ;
    Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J; Widimský P; Waldauf P; Lambert L; Zelinka T; Táborský M; Branny M; Toušek P; Petrák O; Čurila K; Bednář F; Holaj R; Štrauch B; Václavík J; Nykl I; Krátká Z; Kociánová E; Jiravský O; Rappová G; Indra T; Widimský J
    Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial.
    Warchol-Celinska E; Prejbisz A; Kadziela J; Florczak E; Januszewicz M; Michalowska I; Dobrowolski P; Kabat M; Sliwinski P; Klisiewicz A; Topor-Madry R; Narkiewicz K; Somers VK; Sobotka PA; Witkowski A; Januszewicz A
    Hypertension; 2018 Aug; 72(2):381-390. PubMed ID: 29941516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.